糖尿病黄斑水肿和视网膜静脉阻塞眼抗VEGF治疗后黄斑无血管区及黄斑血管密度的光学相干断层扫描血管成像分析
前瞻性非对照病例系列纳入15例患者18只眼(糖尿病黄斑水肿13只眼,视网膜中央静脉阻塞继发黄斑水肿5只眼),在单次玻璃体腔注射抗VEGF前后行OCT血管成像,测量浅层和深层视网膜毛细血管丛黄斑中心及旁中心血管密度与黄斑无血管区面积。结果显示注射前后各指标均无显著差异,糖尿病黄斑水肿眼与视网膜静脉阻塞眼之间各指标平均变化也无显著差异。
要点
- 单次玻璃体腔抗VEGF注射后短期随访,浅层和深层视网膜毛细血管丛黄斑中心及旁中心血管密度均无显著变化(均P>0.1)。
- 黄斑无血管区面积在注射前后亦无显著变化(P=0.48和P=0.42)。
- 糖尿病黄斑水肿眼与视网膜静脉阻塞眼之间血管密度和黄斑无血管区面积的平均变化无显著差异(均P>0.05)。
核心结论
- 在这项先导研究中,单次玻璃体腔注射抗VEGF药物后短期内视网膜毛细血管密度和黄斑无血管区面积保持统计学上无变化。
研究设计与样本
- 前瞻性非对照病例系列,纳入15例患者18只眼,其中糖尿病黄斑水肿13只眼、视网膜中央静脉阻塞继发黄斑水肿5只眼。
- 在玻璃体腔注射前及注射后首次随访时行光学相干断层扫描血管成像,测量浅层和深层视网膜毛细血管丛黄斑中心及旁中心视网膜毛细血管血管密度和黄斑无血管区面积。
主要发现
- 基线与随访光学相干断层扫描血管成像的平均间隔为32.5±9.4天(范围21-50天)。
- 注射前后浅层和深层视网膜毛细血管丛黄斑中心及旁中心血管密度均无显著差异(所有P>0.1)。
- 注射前后黄斑无血管区面积无显著差异(P=0.48和P=0.42)。
- 糖尿病黄斑水肿眼与视网膜静脉阻塞眼在血管密度和黄斑无血管区面积平均变化方面无显著差异(所有P>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文称本研究为先导研究(pilot study)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the changes in foveal avascular zone (FAZ) area and the retinal capillary density after a single intravitreal anti-VEGF injection for macular edema secondary to diabetic retinopathy or retinal vein occlusion. METHODS: In this prospective noncomparative case series, 18 eyes of 15 patients with diabetic macular edema (13 eyes) or macular edema secondary to central retinal vein occlusion (5 eyes) were included. Optical coherence tomography angiography (OCTA) images were obtained, and retinal capillary vessel density and FAZ area were measured in the foveal and parafoveal regions at the level of the superficial (SCP) and deep retinal capillary plexus (DCP) before and at the first visit after intravitreal injection. RESULTS: The mean interval between baseline and follow up OCTA was 32.5 ± 9.4 (range, 21-50) days. Foveal and parafoveal vessel density in the SCP and DCP were not significantly different before and after intravitreal injection (all P > 0.1), nor was FAZ area (P = 0.48 and P = 0.42, respectively). No significant difference was found between eyes with diabetic macular edema and those with retinal vein occlusion with respect to the mean change of vessel density and FAZ area (all P > 0.05). CONCLUSIONS: In this pilot study, retinal capillary density and FAZ area remained statistically unchanged in the short-term after a single intravitreal injection of an anti-VEGF agent.
引用
- Ghasemi Falavarjani K, Iafe NA, Hubschman JP, et al. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Invest Ophthalmol Vis Sci. 2017. PMID: 28114569. doi:10.1167/iovs.16-20579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。